Ledger.Open graph →

SEC Form D · filed August 30, 2022

MyMD Pharmaceuticals, Inc

Offering

$7.4M

Sold

—

Exemption

Rule 506(b)

Industry

Other Health Care

Location

BALTIMORE, MD

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (25)

Jude Uzonwanne · BALTIMORE, MDDirector Joshua Silverman · BALTIMORE, MDDirector Chris Chapman · BALTIMORE, MDExec · Director Craig Eagle · BALTIMORE, MDDirector Bill J. White · BALTIMORE, MDDirector Christopher Schreiber · BALTIMORE, MDDirector Ian Rhodes · BALTIMORE, MDExec Laurence Kleinman · NEW YORK, NYDirector Adam Siegler · NEW YORK, NYDirector Quinn Mcarthur · Dover, DEDirector Brian Cooper · Austin, TXExec Eric Scharaga · Dover, DEDirector Jonson Sun · Vancouver, British Columbia, CanadaDirector Michael Crane · Austin, TXExec · Director Paul Rivard · Baltimore, MDExec Adam Kaplin · Baltimore, MDExec John Fichthorn · Norwalk, CTDirector Charles V. Welden, Iii · Birmingham, ALDirector Kenneth M. Larish · Nashville, TNExec Recof GP · Dallas, TXExec · Director Regan Credit SLP · Dallas, TXDirector Jirka Rysavy · Louisville, CODirector Ned Preston · Louisville, CODirector Paul Rivard · Baltimore, MDExec Adam Kaplin · Baltimore, MDExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗